Invenomic Capital Management’s Matthews International MATW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-185,173
Closed -$4.12M 180
2025
Q1
$4.12M Buy
+185,173
New +$4.82M 0.21% 124
2023
Q1
Sell
-176,093
Closed -$5.36M 164
2022
Q4
$5.36M Buy
176,093
+16,942
+11% +$474K 0.36% 86
2022
Q3
$3.57M Buy
+159,151
New +$4.14M 0.31% 92
2021
Q1
Sell
-62,278
Closed -$1.83M 142
2020
Q4
$1.83M Buy
62,278
+60,400
+3,216% +$1.56M 0.47% 44
2020
Q3
$42K Buy
+1,878
New +$40.3K 0.02% 139

Other funds holding MATW

Invenomic Capital Management's MATW Position: Q2 2025 in Review

Invenomic Capital Management sold out of Matthews International (MATW) in Q2 2025, closing a stake of 185,173 shares — an estimated $4.12M sold.

Invenomic Capital Management first reported a position in MATW in Q3 2020 and held it in 5 quarters. The position peaked at $5.36M in Q4 2022. 161 funds tracked by Wall St. Rank hold MATW as of Q2 2025.

  • Invenomic Capital Management reported no remaining Matthews International position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 185,173 Matthews International shares in Q2 2025, an estimated $4.12M.
  • Invenomic Capital Management first reported a position in Matthews International in Q3 2020 and held it in 5 quarters.
  • Invenomic Capital Management's Matthews International position peaked at $5.36M in Q4 2022.
  • 161 funds tracked by Wall St. Rank held Matthews International as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.